ConductScience.org, home

Paper6842003

Selective antimicrobial modulation as prophylaxis against infection during granulocytopenia: trimethoprim-sulfamethoxazole vs. nalidixic acid.

Wade JC and 5 others. J Infect Dis, 1983. Cited by 106 papers, by iCite.

Cite this record

ConductScience Library. Selective antimicrobial modulation as prophylaxis against infection during granulocytopenia: trimethoprim-sulfamethoxazole vs. nalidixic acid. Papers, record 6842003. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6842003

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Selective antimicrobial modulation as prophylaxis against infection during granulocytopenia: trimethoprim-sulfamethoxazole vs. nalidixic acid.
PubMed
Journal
J Infect Dis
PubMed
Year
1983
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
106
iCite
Relative citation ratio, by iCite
5.71
iCite
Revised in PubMed
2026-01-28
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wade JCJ C
2de Jongh CAC A
3Newman KAK A
4Crowley JJ
5Wiernik PHP H
6Schimpff SCS C

Source PubMed

Download CSV of authors

Topics22

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AgranulocytosisMajor topic
Bacterial InfectionsMajor topic
LeukemiaMajor topic
Nalidixic AcidMajor topic
SulfamethizoleMajor topic
SulfathiazolesMajor topic
TrimethoprimMajor topic
Adolescent
Adult
Aged
Child
Drug Combinations
Female
Humans
Male
Middle Aged
Mycoses
Nystatin
Patient Compliance
Prospective Studies
Random Allocation
Benzenesulfonamides

Source PubMed

Download CSV of topics

Cited by24

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 106 citations.

PMIDTitleJournalYearIn PapersSource
22258955Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy.Cochrane Database Syst Rev2012https://conductscience.org/library/papers/22258955PubMed
15227389Trimethoprim- sulfamethoxazole: pharmacokinetics, clinical uses, and adverse reactions.Tex Heart Inst J1990https://conductscience.org/library/papers/15227389PubMed
9227863Antifungal prophylaxis during neutropenia and immunodeficiency.Clin Microbiol Rev1997https://conductscience.org/library/papers/9227863PubMed
8460916Oral enoxacin for infection prevention in adults with acute nonlymphocytic leukemia. The Enoxacin Prophylaxis Study Group.Antimicrob Agents Chemother1993https://conductscience.org/library/papers/8460916PubMed
8156265Salmonella infections in a cancer center.Support Care Cancer1994https://conductscience.org/library/papers/8156265PubMed
3960694The place of quinolones in antibacterial therapy in hospitals.Pharm Weekbl Sci1986https://conductscience.org/library/papers/3960694PubMed
3729360Selective antimicrobial modulation of the intestinal tract by norfloxacin in human volunteers and in gnotobiotic mice associated with a human fecal flora.Antimicrob Agents Chemother1986https://conductscience.org/library/papers/3729360PubMed
3666959Role of anaerobic flora in the translocation of aerobic and facultatively anaerobic intestinal bacteria.Infect Immun1987https://conductscience.org/library/papers/3666959PubMed
3549037Antibacterial therapy in patients with malignancies.Cancer Metastasis Rev1987https://conductscience.org/library/papers/3549037PubMed
3491791Prevention of infection in acute leukemia: a prospective randomized study on the efficacy of two different drug regimens for antimicrobial prophylaxis.Infection1986https://conductscience.org/library/papers/3491791PubMed
3481358Ofloxacin for prevention of bacterial infections in granulocytopenic patients.Infection1987https://conductscience.org/library/papers/3481358PubMed
3477669High risk of streptococcal septicemia after high dose cytosine arabinoside treatment for acute myelogenous leukemia.Klin Wochenschr1987https://conductscience.org/library/papers/3477669PubMed
3325929Ciprofloxacin for infection prevention in patients with acute leukemia.Pharm Weekbl Sci1987https://conductscience.org/library/papers/3325929PubMed
3325435Hematological side effects of co-trimoxazole.Infection1987https://conductscience.org/library/papers/3325435PubMed
3325256Antimicrobial prophylaxis in immunocompromised patients.Drugs1987https://conductscience.org/library/papers/3325256PubMed
3312287
Comparison of a novel trimethoprim-sulfamethoxazole-containing medium (XT80) with kanamycin agar for isolation of antibiotic-resistant organisms from stool and rectal cultures of marrow transplant patients.
J Clin Microbiol1987https://conductscience.org/library/papers/3312287PubMed
3300532
Selective gut decontamination with nalidixic acid or trimethoprim-sulfamethoxazole for infection prophylaxis in neutropenic cancer patients: relationship of efficacy to antimicrobial spectrum and timing of administration.
Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3300532PubMed
3132368Role of intestinal anaerobic bacteria in colonization resistance.Eur J Clin Microbiol Infect Dis1988https://conductscience.org/library/papers/3132368PubMed
3028964Bacteriological data on a prospective multicenter study of the effect of two different regimens for selective decontamination in patients with acute leukaemia.Infection1986https://conductscience.org/library/papers/3028964PubMed
2938072Quinolones and colonization resistance in human volunteers.Pharm Weekbl Sci1986https://conductscience.org/library/papers/2938072PubMed

See all 24 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6842003

GET https://conductscience.org/api/papers/v1/6842003/cited_by?page=2